摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,6,7,8-Tetrahydro-1,3-dithiolo<4,5-b><1,4>dithiocine-2-thione | 139197-46-9

中文名称
——
中文别名
——
英文名称
5,6,7,8-Tetrahydro-1,3-dithiolo<4,5-b><1,4>dithiocine-2-thione
英文别名
5,6,7,8-Tetrahydro-[1,3]dithiolo[4,5-b][1,4]dithiocine-2-thione
5,6,7,8-Tetrahydro-1,3-dithiolo<4,5-b><1,4>dithiocine-2-thione化学式
CAS
139197-46-9
化学式
C7H8S5
mdl
——
分子量
252.471
InChiKey
OVFUWIVIBIVLBS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    382.7±52.0 °C(Predicted)
  • 密度:
    1.56±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    133
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • IDO Inhibitors
    申请人:Mautino Mario
    公开号:US20110053941A1
    公开(公告)日:2011-03-03
    Presently provided are methods for (a) modulating an activity of indoleamine 2,3-dioxygenase comprising contacting an indoleamine 2,3-dioxygenase with a modulation effective amount of a compound as described in one of the aspects described herein; (b) treating indoleamine 2,3-dioxygenase (IDO) mediated immunosuppression in a subject in need thereof, comprising administering an effective indoleamine 2,3-dioxygenase inhibiting amount of a compound as described in one of the aspects described herein; (c) treating a medical conditions that benefit from the inhibition of enzymatic activity of indoleamine-2,3-dioxygenase comprising administering an effective indoleamine 2,3-dioxygenase inhibiting amount of a compound as described in one of the aspects described herein; (d) enhancing the effectiveness of an anti-cancer treatment comprising administering an anti-cancer agent and a compound as described in one of the aspects described herein; (e) treating tumor-specific immunosuppression associated with cancer comprising administering an effective indoleamine 2,3-dioxygenase inhibiting amount of a compound as described in one of the aspects described herein; and (f) treating immunosuppression associated with an infectious disease, e.g., HIV-I infection, comprising administering an effective indoleamine 2,3-dioxygenase inhibiting amount a compound as described in one of the aspects described herein.
    目前提供以下方法:(a) 通过接触本文中描述的化合物的调节有效量与吲哚胺2,3-二氧化酶相互作用,从而调节吲哚胺2,3-二氧化酶的活性;(b) 治疗需要吲哚胺2,3-二氧化酶(IDO)介导的免疫抑制的患者,包括给予本文中描述的化合物的有效吲哚胺2,3-二氧化酶抑制剂量;(c) 治疗需要抑制吲哚胺-2,3-二氧化酶酶活性的医疗状况,包括给予本文中描述的化合物的有效吲哚胺2,3-二氧化酶抑制剂量;(d) 增强抗癌治疗的有效性,包括给予抗癌剂和本文中描述的化合物;(e) 治疗与癌症相关的肿瘤特异性免疫抑制,包括给予本文中描述的化合物的有效吲哚胺2,3-二氧化酶抑制剂量;(f) 治疗与传染病相关的免疫抑制,例如HIV-1感染,包括给予本文中描述的化合物的有效吲哚胺2,3-二氧化酶抑制剂量。
  • Sulfur-rich CpCo(dithiolene) complexes: Isostructural or non-isostructural couples of CpCo(III) with CpNi(III) dithiolene complexes
    作者:Mitsushiro Nomura、Shigemi Kondo、Souichi Yamashita、Eriko Suzuki、Yoshiko Toyota、Glenn V. Alea、Gerardo C. Janairo、Chikako Fujita-Takayama、Toru Sugiyama、Masatsugu Kajitani
    DOI:10.1016/j.jorganchem.2010.05.024
    日期:2010.10
    Eight new sulfur-rich [CpCo(dithiolene)] complexes were synthesized from [Zn(dmit)(2)](2-) as a starting material. The structures, electrochemical behavior and electronic absorption spectra of the sulfur-rich [CpCo(S2C2S2Y)] complexes could be compared with the early data of analogous Ni complexes. [CpCo (pddt)] (Y= -(CH2)(3)-), [CpCo(dpdt)] (Y = -CH2C(CH2)CH2-), [CpCo(bddt)] (Y = -(CH2)(4)-), [CpCo(dtdt)] (Y = -CH2SCH2-) and [CpCo(poddt)] (Y = -CH2C(O)CH2-) crystallized in all isostructural with the corresponding paramagnetic [CpNi(dithiolene)](center dot) complexes, but [CpCo(dmid)] (Y =C=O), [CpCo(dddt)] (Y= -(CH2)(2)-) and [CpCo(F(2)pddt)] (Y= -CH2CF2CH2-) crystallized in non-isostructural with them. These molecules are associated with intermolecular short S center dot center dot center dot S contacts in the crystals. [CpCo(F(2)pddt)] did not show any remarkable S center dot center dot center dot S contacts but indicated interesting fluorine segregation and Cp center dot center dot center dot Cp face-to-face interactions. Redox potentials of [CpCo(dithiolene)] complexes were obtained with the cyclic voltammetry measurements and dimerized by electrochemical oxidations. Electronic absorption spectra of [CpCo(dithiolene)] complexes showed visible absorption in the range of 585-701 nm as lowest energy wavelengths (epsilon = 9800-11,800 M-1 cm(-1)) in solutions, and they were higher energy than those of [CpNi (dithiolene)](center dot) complexes (near-IR). (C) 2010 Elsevier B.V. All rights reserved.
查看更多

同类化合物

(Rp)-2-(叔丁硫基)-1-(二苯基膦基)二茂铁 (1E)-1-{4-[(4-氨基苯基)硫烷基]苯基}乙酮肟 颜料红88 颜料紫36 顺式-1,2-二(乙硫基)-1-丙烯 非班太尔-D6 雷西那得中间体 阿西替尼杂质J 阿西替尼杂质C 阿西替尼杂质4 阿西替尼杂质 阿西替尼 阿拉氟韦 阿扎毒素 阿嗪米特 阔草特 银(I)(6-氨基-2-(甲硫基)-5-亚硝基嘧啶-4-基)酰胺水合物 钾三氟[3-(苯基硫基)丙基]硼酸酯(1-) 邻甲苯基(对甲苯基)硫化物 避虫醇 连翘脂苷B 还原红 41 还原紫3 还原桃红R 达索尼兴 辛硫醚 辛-1,7-二炔-1-基(苯基)硫烷 西嗪草酮 萘,2-[(2,3-二甲基苯基)硫代]- 莫他哌那非 茴香硫醚 苯醌B 苯酰胺,N-(氨基亚氨基甲基)-4-[(2-甲基苯基)硫代]-3-(甲磺酰)-,盐酸盐 苯酰胺,N-(氨基亚氨基甲基)-4-[(2-氯苯基)硫代]-3-(甲磺酰)-,盐酸盐 苯酰胺,N-(氨基亚氨基甲基)-4-[(2,6-二氯苯基)硫代]-3-(甲磺酰)-,盐酸盐 苯酰胺,2-[(2-硝基苯基)硫代]- 苯酚,3-氯-4-[(4-硝基苯基)硫代]- 苯酚,3-(乙硫基)- 苯酚,3,5-二[(苯基硫代)甲基]- 苯胺,4-[5-溴-3-[4-(甲硫基)苯基]-2-噻嗯基]- 苯胺,3-氯-4-[(1-甲基-1H-咪唑-2-基)硫代]- 苯胺,2-[(2-吡啶基甲基)硫代]- 苯硫醚-D10 苯硫胍 苯硫基乙酸 苯硫代磺酸S-(三氯乙烯基)酯 苯甲醇,2,3,4,5,6-五氟-a-[(苯基硫代)甲基]-,(R)- 苯甲酸,3-[[2-[(二甲氨基)甲基]苯基]硫代]-,盐酸 苯甲胺,5-氟-2-((3-甲氧苯基)硫代)-N,N-二甲基-,盐酸 苯甲二硫酸,4-溴苯基酯